Mercury Labs (538964)
STALWARTScore breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,021 |
| Market Cap | ₹127.87 Cr |
| P/E Ratio | 20.1 |
| ROCE | 8.94% |
| ROE | 9.13% |
| Dividend Yield | 0.42% |
| Profit Growth | 3.36% |
| Debt/Equity | — |
| Sales Growth | -6.23% |
| 52-Week Range | ₹620.55 — ₹1,021 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹450.54 |
Mercury Labs trades with a P/E ratio of 20.1, ROCE of 8.94%, ROE of 9.13%, profit growth of 3.36%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer